Quantcast

Latest Stem cell treatments Stories

2014-08-08 08:25:57

GERMANTOWN, Md., Aug. 8, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months and six months ended June 30, 2014 and provided a business and clinical update. "We are pleased to report that 2014 has already seen the company achieve several major milestones. In late July, we completed the last of the surgeries in the NSI-566/ALS Phase II trial. Each of the patients in the final cohort have received a total of 16 million NSI-566 neural...

2014-08-04 08:29:33

GERMANTOWN, Md., Aug. 4, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The multicenter Phase II trial treated 15 ambulatory patients in five different dosing cohorts. The first 12 patients received injections in the cervical region of the spinal cord only, where the stem cells...

2014-07-28 23:05:32

Medical discoveries continue to reveal the many uses for which stem cell treatment can be used, ranging from kidney disease to brain damage. A recent case study conducted by Skinspirations demonstrated the healing results that stem cell treatment induces in patients with osteoarthritis. Tampa Bay, FL (PRWEB) July 28, 2014 Nearly 53 million Americans today are suffering with arthritis, with the majority of them diagnosed with osteoarthritis. (1) Osteoarthritis is a degeneration of joint...

2014-07-28 23:03:19

Transparency Market Research has announced the addition of the "Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" report to their offering. Browse the full report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html. (PRWEB) July 28, 2014 According to a new market research report published by Transparency Market Research "Regenerative Medicine (Bone and Joint) Market (By Technology - Stem...

2014-07-24 16:24:57

COSTA MESA, Calif., July 24, 2014 /PRNewswire/ -- Now available is a stem cell therapy that is incredibly close to home. Rehealth Regenerative Therapies, located in Guadalajara, Mexico, is offering athletes and other physically active people a new health option: stem cell therapies for sports injuries. Regardless of age, countless patients suffer from joint and muscle injuries due to professional or amateur sport activities, such as muscle tears, torn rotator cuff, tennis elbow, and...

2014-07-23 23:28:46

The minimally invasive and holistic stem cell therapy brings a new ray of hope for patients suffering from bone degeneration and arthritis conditions. Los Angeles, CA (PRWEB) July 22, 2014 MetroMD, one of the leading names in regenerative medicines in all of California and one of the greatest proponents of holistic health services, now brings a reason to rejoice for individuals long suffering from debilitating arthritis. As per a report published on March 6 2013, by ‘The Journal of Bone...

2014-07-23 23:13:54

Many current regenerative medicine trials are based on heterologous stem cell transplantation, in which stem cells multiplied from one type of organ or tissue are transferred to treat diseases, disorders, or injuries in a different type of organ or tissue. Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) continues to develop technologies that could allow as well natural, homologous stem cell transplantation therapies for more human organs and tissues. Boston, MA (PRWEB) July 23,...

2014-07-23 04:21:31

HONG KONG, July 23, 2014 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, and Cordlife Group Limited ("Cordlife"), a multi-product healthcare company catering to the mother and child segment, today announced that the two companies have joined forces in assisting patients across the PRC, Singapore, Hong...

2014-07-17 16:25:49

NEW YORK, July 17, 2014 /PRNewswire/ -- According to a new market research report published by Transparency Market Research "Regenerative Medicine (Bone and Joint) Market (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global regenerative medicine...

2014-07-17 16:25:37

NEW YORK, July 17, 2014 /PRNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today ViaCyte, Inc., a leading regenerative medicine company, has filed an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of the VC-01(TM) product candidate, a stem...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'